Healthcare | April 05, 2024
Aster DM Healthcare concludes separation of India and GCC businesses
The company plans to add 1700 beds by FY27 through the organic route
The company plans to add 1700 beds by FY27 through the organic route
Combination will create a Canadian Health Champion spanning generic, biosimilar and branded pharmaceuticals
The CRDMO site will add 120,000L manufacturing capacity to WuXi Biologics’ global network
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
Under the arrangement, Dr. Reddy's will have exclusive rights to promote and distribute Sanofi's vaccine brands Hexaxim, Pentaxim, Tetraxim, Menactra, FluQuadri, Adacel and Avaxim 80U
Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
First and only long-acting C5 complement inhibitor offers patients with AQP4 Ab+
WINREVAIR is a breakthrough biologic for this rare, progressive disease
Centhaquine is a resuscitative agent presently indicated for the treatment of hypovolemic shock by DGCI
The MDC business produces components for medical device manufacturers globally with a focus on precious metal alloys and nitinol
Subscribe To Our Newsletter & Stay Updated
